References and Notes
-
1a
Kent SBH.
Chem. Soc.
Rev.
2009,
38:
338
-
1b
Muir TW.
Annu. Rev. Biochem.
2003,
72:
249
- 2
Crich D.
Sasaki K.
Rahaman MdY.
Bowers AA.
J. Org.
Chem.
2009,
74:
3886
-
3a
Haung H.
Carey RI.
J.
Peptide Res.
1998,
51:
290
-
3b
Hadad CM.
Rablen PR.
Wiberg KB.
J. Org. Chem.
1998,
63:
8668
- 4
Barlett KN.
Kolakowski RV.
Katukojvala S.
Williams LJ.
Org.
Lett.
2006,
8:
823
-
5a
Blake J.
Int. J. Pept. Protein Res.
1981,
17:
273
-
5b
Yamashiro D.
Blake J.
Int. J. Pept. Protein Res.
1981,
18:
383
-
5c
Mitin YV.
Zapevalova NP.
Int.
J. Pept. Protein Res.
1990,
35:
352
-
6a
Wu X.
Stockdill JL.
Wang P.
Danishefsky SJ.
J.
Am. Chem. Soc.
2010,
132:
4098
-
6b
Rao Yu.
Li X.
Danishefsky SJ.
J.
Am. Chem. Soc.
2009,
131:
12924
-
7a
Park S.-D.
Oh J.-H.
Lim D.
Tetrahedron Lett.
2002,
43:
6309
-
7b
Fazio F.
Wong C.-H.
Tetrahedron Lett.
2003,
44:
9083
-
7c
Mckervey MA.
O’Sullivan MB.
Mayers PL.
Green RH.
J. Chem. Soc., Chem. Commun.
1993,
94
-
8a
Shangguna N.
Katukojvala S.
Greenberg R.
Williams LJ.
J.
Am. Chem. Soc.
2003,
125:
7754
-
8b
Merkx R.
van Haren MJ.
Rijkers Drik TS.
Liskamp RMJ.
J.
Org. Chem.
2007,
72:
4574
- 9
Crich D.
Sasaki K.
Org. Lett.
2009,
11:
3514
- 10
Assem N.
Natarajan A.
Yudin AK.
J.
Am. Chem. Soc.
2010,
132:
10986
- 11
Crich D.
Sharma I.
Angew. Chem. Int. Ed.
2009,
48:
2355
- 12
Fu X.
Jiang S.
Li C.
Xin J.
Yang Y.
Ji R.
Bioorg. Med.
Chem. Lett.
2007,
17:
465
- 13
Kolb J.
Beck B.
Almstetter M.
Heck S.
Herdtweck E.
Dömling A.
Mol. Diversity
2003,
6:
297
- 14
Yazmin T.
Rosa-Bauza Berst F.
Ellman JA.
ChemBioChem.
2007,
8:
981
-
15a
Le H.-T.
Gallard J.-F.
Mayer M.
Guittet E.
Michelot R.
Bioorg. Med. Chem.
1996,
4:
2201
-
15b
Hoeg-Jensen T.
Jakobsen H.
Olsen CE.
Holm A.
Tetrahedron Lett.
1991,
32:
7617
-
15c
Hoeg-Jensen T.
Holm A.
Sorensen H.
Synthesis
1994,
383
-
16a
Crich D.
Sana K.
Guo S.
Org. Lett.
2007,
9:
4423
-
16b
Crich D.
Sharma I.
Angew. Chem. Int. Ed.
2009,
48:
2355
- 17
Rao Y.
Li X.
Nagorny P.
Hayashida J.
Danishefsky
SJ.
Tetrahedron
Lett.
2009,
50:
6684
- 18
Monfardini I.
Huang J.-W.
Beck B.
Cellitti JF.
Pellecchai M.
Dömling A.
J. Med. Chem.
2011,
54:
890
- 19
Schwabacher AW.
Maynard TL.
Tetrahedron Lett.
1993,
34:
1269
- 20
Tan X.-H.
Yang R.
Wirjo A.
Liu C.-F.
Tetrahedron Lett.
2008,
49:
2891
- 21
Zhang X.
Lu X.-W.
Liu C.-F.
Tetrahedron
Lett.
2008,
49:
6122
- 22
Shigenaga A.
Sumikawa Y.
Tsuda S.
Sato S.
Otaka A.
Tetrahedron
2010,
66:
3290
-
23a
Wang P.
Danishefsky SJ.
J.
Am. Chem. Soc.
2010,
132:
17045
-
23b
Wang P.
Li X.
Zhu J.
Chen J.
Yuan Y.
Wu X.
Danishefsky SJ.
J. Am. Chem.
Soc.
2011,
133:
1597
- 24
Pan J.
Nelmi O.
Devarie B.
Xian M.
Org.
Lett.
2011,
13:
1092
- 25
Goyal N.
Synlett
2010,
335 ; and references cited therein
- 26
Sureshbabu VV.
Lalithamba HS.
Narandra N.
Hemantha HP.
Org. Biomol. Chem.
2010,
8:
835
-
27a
General Procedure for the Preparation of Peptide Acids
A
solution of Nα-protected amino acid (1 mmol)
in dry CH2Cl2 (5 mL) was cooled to 0 ˚C,
EDC (1 mmol), HOBt (1.2 mmol), and O,N-bis-TMS-amino acid (1.5 mmol) were added.
The reaction mixture was stirred for 3-4 h (TLC analysis),
and then evaporation of the solvent and acidification with 1 M HCl
furnished pure peptide acid.
-
27b For the preparation of O,N-bis-TMS-amino
acids, see: Tantry SJ.
Vasanthakumar G.-R.
Sureshbabu VV.
Lett. Pept.
Sci.
2003,
10:
51
28
General Procedure
for the Synthesis of Amino/Peptide Thioacids
To
a DMF solution of an acid (1.0 mmol), EDC (1.1 equiv) was added
at 0 ˚C under a nitrogen atmosphere. After stirring
for 10 min, finely ground Na2S (3 equiv) was added to
the reaction mixture which was allowed for stir for 3-4
h until the disappearance of the starting material (TLC analysis).
The residue was dissolved in EtOAc (15 mL), and the solution was
then carefully acidified at 0 ˚C to a pH of 3 by
using 1 M KHSO4. The organic layer was then immediately
separated and removed under reduced pressure. The crude product
was triturated with Et2O or recrystallized with THF-H2O
to obtain pure thioacid.
29
Fmoc-Ile-COSH
Yellow
solid; mp 81-83 ˚C. IR (KBr): νmax = 1689,
1739, 2550, 3342 cm-¹. R
f
= 0.39
(EtOAc-n-hexane = 60:40).
RP-HPLC: t
R = 15.2
(60-100% MeCN, 30 min). ESI-HRMS:
m/z calcd for C21H23NO3S:
392.1296 [M + Na]+;
found: 392.1290. ¹H NMR (400 MHz, CDCl3): δ = 0.88
(t, J = 5.6 Hz,
3 H), 0.98 (d, J = 3.8
Hz, 3 H), 1.12-1.24 (m, 2 H), 2.38-2.47 (m, 1
H), 4.28 (d, J = 6.7
Hz, 1 H), 4.37 (d, J = 7.1
Hz, 1 H), 4.61 (d, J = 4.4
Hz, 2 H), 5.91 (br s, 1 H), 7.43 (br s, 1 H), 7.26-7.84
(m, 8 H). ¹³C NMR (100 MHz, CDCl3): δ = 10.8, 14.3,
24.1, 37.0, 46.4, 65.9, 72.8, 125.9, 127.3, 128.6, 128.9, 139.2,
142.6, 155.2, 197.2.
30
Fmoc-Ala-Phe-COSH
White
solid; mp 126-128 ˚C. IR (KBr): νmax = 1681,
1748, 1768, 2549, 3328 cm-¹. R
f
= 0.53
(CHCl3-MeOH = 80:20). RP-HPLC: t
R = 11.4 (60-100% MeCN,
30 min). ESI-HRMS: m/z calcd
for C27H26N2O4S: 497.1511 [M + Na]+; found:
497.1501. ¹H NMR (400 MHz, CDCl3): δ = 1.2
(d, J = 4.8
Hz, 3 H), 2.6 (d, J = 5.6
Hz, 2 H), 2.8 (br s, 1 H), 3.38 (t, J = 7.4
Hz, 1 H), 3.6 (br s, 1 H), 3.9 (t, J = 6.9
Hz, 2 H), 4.1 (m, 1 H), 4.3 (m, 1 H), 6.32 (br s, 1 H), 7.1 (br
s, 1 H), 7.2-7.9 (m, 13 H). ¹³C
NMR (100 MHz, CDCl3): δ = 17.2, 37.4,
46.8, 51.2, 67.9, 69.7, 125.7, 126.8, 127.2, 127.9, 128.4, 128.9,
131.2, 139.1, 141.4, 143.2, 155.7, 172.1, 197.2.
31 Chiral-HPLC analyses were carried
out employing Chiralpak IA, 250 × 4.6
mm; solvent: hexane-EtOH (7:3); flow rate: 1.0 mL/min.